List view / Grid view

Prof Axel Glasmacher (University of Bonn)

 

article

United efforts to accelerate drug development

22 December 2021 | By , ,

From the Cancer Drug Development Forum (CDDF), John Smyth (Chairman), Axel Glasmacher (Treasurer) and Jaap Verweij (Managing Director) clarify the importance of a collaborative industry approach to cancer therapy development and highlight the most pressing challenges for discussion in their meetings and workshops.